Navigation Links
ConvaTec Names Nigel Clerkin Chief Financial Officer
Date:7/22/2014

LUXEMBOURG, July 22, 2014 /PRNewswire/ -- ConvaTec, a privately-held medical products and technologies company, today announced that Nigel Clerkin has been appointed chief financial officer of the company, effective July 22, 2014.

Mr. Clerkin was previously executive vice president and chief financial officer of Elan Corporation, a Dublin-based biotechnology company.  Mr. Clerkin was part of a senior team that helped build significant shareholder value at Elan, culminating in its sale to Perrigo, a pharmaceutical manufacturer, in December 2013.

"I am very pleased to welcome Nigel to ConvaTec," said Ken Berger, CEO of ConvaTec. "His track record in creating value at a major public company will be a great asset for us as we grow and evolve as a company."

"ConvaTec has outstanding products, a great reputation and a proven business platform that is primed to take advantage of emerging healthcare trends," said Mr. Clerkin.  "I am delighted to join ConvaTec at a very exciting time for the company."

Mr. Clerkin joined Elan in 1998 and held a series of roles in strategic planning and finance prior to being named CFO in 2011.  Earlier, Mr. Clerkin was an auditor with KPMG.  He holds bachelor's and master's degrees in accounting from Queens University, Belfast, and is a fellow of Chartered Accountants Ireland.

Mr. Clerkin succeeds John Cannon, who will remain at ConvaTec as senior vice president, financial operations.

About ConvaTec
ConvaTec is a global medical products and technologies company, with leading market positions in wound therapeutics, ostomy care, continence and critical care, and infusion devices. Our products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. ConvaTec has over 8,000 employees, with 11 manufacturing sites in 8 countries, and we do business in more than 100 countries. We are owned by Nordic Capital and Avista Capital Partners. More information is available at www.convatec.com.

Contacts

Media:
Punnie Donohue
ConvaTec
1-908-904-2151
punnie.donohue@convatec.com

Investors:
Bob McKee
ConvaTec
1-336-547-3701
bob.mckee@convatec.com


'/>"/>
SOURCE ConvaTec
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. ConvaTec Announces 2013 Third Quarter Earnings Call
2. ConvaTec Announces 2013 Second Quarter Earnings Call
3. ConvaTec Announces 2013 First Quarter Earnings Call
4. ConvaTec Announces 2012 Year-End Earnings Call
5. ConvaTec, A Leader In Antimicrobial Dressings And Infection Management, To Host Live International Webcast On Minimizing Risk Of Wound Infections
6. ConvaTec To Acquire Intermittent Catheter Provider
7. ConvaTec Introduces Enhanced Flexi-Seal® SIGNAL® FMS
8. ConvaTec Announces Acquisition of AbViser Medical, LLC
9. ConvaTec Donates $10,000 To AAWC Global Volunteers Program Through SAWC Walk For Wellness
10. Aptuit Names Dr. Paul Overton Executive VP, Business Development & Marketing; Enhances Sterile Drug Product Capabilities
11. Express Scripts Names Cathy R. Smith Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... MINNEAPOLIS , Feb. 23, 2017  Cogentix Medical, ... manufactures and markets innovative proprietary products for the urology ... and fiscal year ended December 31, 2016 before the ... The Company will host a conference call and ... on Thursday, March 9, 2017 at 11:00 a.m. Eastern ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of the ... their offering. ... research Menopause Drugs Price Analysis and Strategies - 2016, provides drug pricing ... the following questions: What are the key ... in the Global Menopause market? What are the unit ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... - 2016" report to their offering. ... The latest research Fibromyalgia Drugs Price ... in the global Fibromyalgia market. The research answers the ... marketed for Fibromyalgia and their clinical attributes? How are they positioned ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, ... June: From Not to Hot,” which will begin airing on February 24, 2017. The ... millions from the 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... will host a diverse symposium on “Doping in Sport: How the Culture ... Mullin Richter & Hampton LLP. The symposium will be held at Pepperdine University ...
(Date:2/23/2017)... ... , ... Current Meditation , a new meditation concept ... U.S. starting this spring. Current Meditation focuses on “meditation for the modern world,” ... will be the first meditation concept in the U.S. offering franchising opportunities, setting ...
(Date:2/23/2017)... ... February 23, 2017 , ... CALNOC, the nation’s first and ... keynote their upcoming conference – Empowerment, Value and Collaboration – in Seattle, WA on ... of the Virginia Mason Health System in Seattle since 2000. In addition to his ...
(Date:2/23/2017)... ... 23, 2017 , ... Thomas Vas-Don suffered from severe injury due ... was able to successfully recover. In “ Origin & Insertion Charts for Massage Therapists ... the principals of massage, anatomy , trigger points and referral pain patterns ...
Breaking Medicine News(10 mins):